Explore how AI is revolutionizing psychology education, diagnosis, and treatment, addressing mental health challenges and ...
Data from the SERENITY At-Home Phase 3 trial were presented on November 7 at the 2025 Neuroscience Education Institute Fall Congress by Dr. Leslie Citrome.
Teva Pharmaceuticals has announced new real-world data showing that AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR ...
TipRanks on MSN
BioXcel Presents Phase 3 Study on BXCL501
Bioxcel Therapeutics ( ($BTAI) ) has provided an update. On November 10, 2025, BioXcel Therapeutics announced the presentation of their Phase 3 ...
In this diverse cohort of patients with first-time psychotic spectrum disorders (PSDs), 45.7% were diagnosed in outpatient psychiatry clinics, and 42.0% were diagnosed in the emergency department (ED) ...
AI transforms healthcare by enhancing disease detection, patient care and hospital efficiency but requires careful implementation to ensure equity and effectiveness. Managed Healthcare Executive ...
In an era where sexual dysfunction, marital discord, rising anxiety and depression are increasingly widespread in urban and ...
When should therapists lead, and when should they listen? Here's how to balance directive vs non-directive therapy with ...
Peake relates the story of folk music legend Woody Guthrie, “our greatest advocate,” if only by accident. The ...
Company plans to request re-examination after CHMP opinion feedback following its oral explanation FDA advises Company to meet and discuss Company’s Alzheimer's Disease clinical trial results NEW YORK ...
Investing.com -- Anavex Life Sciences Corp. (NASDAQ:AVXL) stock plummeted 50% after the company received a negative trend vote from the European Medicines Agency’s Committee for Medicinal Products for ...
For the Financial Times (FT) Global Pharma & Biotech Summit in London 2025, pharmaphorum is providing coverage courtesy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback